Michelle Teplensky

Michelle Teplensky is a Professor at Boston University, where she leads the Teplensky Lab at the intersection of nanomaterials and immune system programming. Her research integrates nanochemistry, bioengineering, and immunology to develop advanced therapies and vaccines for cancer and infectious diseases.

• Research focuses on controlling immunological activity through synthetic nanoscale advances
• Labs emphasizes elucidating design rules for therapeutic development

She was awarded the Beckman Young Investigator Program in 2024 and received the NIH NIGMS R35 Award in 2025 to advance her work on nanomaterials and immunology. Her interdisciplinary approach spans chemistry, nanotechnology, and biomaterials design.